The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCppgroup Regulatory News (CPP)

Share Price Information for Cppgroup (CPP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 173.00
Bid: 165.00
Ask: 181.00
Change: 3.00 (1.76%)
Spread: 16.00 (9.697%)
Open: 170.00
High: 0.00
Low: 0.00
Prev. Close: 170.00
CPP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Overallotment option exercise notice

16 Apr 2010 16:52

RNS Number : 3504K
CPPGroup Plc
16 April 2010
 

 

 

 

TO BE RELEASED OUTSIDE THE UNITED STATES ONLY. NOT FOR DISTRIBUTION DIRECTLY OR INDIRECTLY IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, SWITZERLAND, SOUTH AFRICA OR JAPAN

 

FOR IMMEDIATE RELEASE 16 APRIL 2010

Overallotment option exercise notice: CPPGroup Plc

 

In connection with the Global Offer in relation to the following Ordinary Shares:

CPPGroup Plc Ordinary Shares of 10p each

ISIN Code: GB00B5W55H93

 

CPPGroup Plc ("CPP") announces that, in connection with the Global Offer of 63,829,786 Ordinary Shares by CPP, UBS Limited, as stabilising manager, has today given notice to exercise the Over-allotment Option in respect of 6,382,978 Ordinary Shares

 

Including the exercise of the Over-allotment Option, the total number of Ordinary Shares in the Global Offer is 70,212,764. Following the exercise of the Over-allotment Option, Hamish Ogston will own approximately 57.5 per cent. of CPP's Ordinary Shares.

 

The issue price of CPPGroup Plc Ordinary Shares of 10p each was set at 235p on 18 March 2010.

 

The stabilisation period commenced at 8am on 19 March 2010 and ended at the close of business on 16 April 2010

 

 

IMPORTANT NOTICE

 

This announcement is not for publication or distribution, directly or indirectly, in or into the United States. The distribution of this announcement may be restricted by law in certain jurisdictions and persons into whose possession any document or other information referred to herein comes should inform themselves about and observe any such restriction. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction.

 

J.P. Morgan Securities Ltd. and UBS Limited (together, the "Banks") are acting as joint sponsors, joint lead managers, joint global co-ordinators and joint bookrunners in connection with Admission and the Global Offer and as underwriters in connection with the Global Offer.

 

The Banks are acting exclusively for the Company and no-one else in connection with the Global Offer. They will not regard any other person as their client in relation to the Global Offer and will not be responsible to anyone other than the Company for providing the protections afforded to customers of the Banks or for giving advice in relation to the Global Offer, the contents of this announcement or any transaction, arrangement or other matter referred to herein.

 

This announcement does not contain or constitute an offer, or the solicitation of an offer to buy or subscribe for Ordinary Shares, and is not for distribution in, the United States, Canada, Australia, Switzerland, South Africa or Japan, or in any jurisdiction in which distribution is unlawful. The Ordinary Shares have not been and will not be registered under the US Securities Act of 1933, as amended (the "Securities Act") or under the securities laws of South Africa, Canada, Switzerland, Australia or Japan, and may not be offered, sold, transferred or delivered, directly or indirectly, in or into the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and in compliance with any applicable securities laws of any states or other jurisdiction of the United States.

 

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of CPP in any jurisdiction.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCGGUQPCUPUGAQ
Date   Source Headline
8th May 20247:00 amRNSResult of AGM
23rd Apr 20247:00 amRNSBlock listing Interim Review
3rd Apr 202410:29 amRNSPosting of Annual Report and Notice of AGM
26th Mar 20247:00 amRNSFULL YEAR RESULTS FOR YEAR ENDED 31 DECEMBER 2023
20th Mar 20242:12 pmRNSInvestor presentation via Investor Meet Company
15th Feb 20242:31 pmRNSDivestment of minority holding in KYND Limited
22nd Jan 20247:00 amRNSTrading Update for Financial Year 2023
11th Jan 20247:00 amRNSBlink progress in 2023
21st Dec 20237:00 amRNSBlock Listing of Ordinary Shares
20th Dec 20237:00 amRNSBlink Parametric signs Blue Cross extension
18th Dec 20237:00 amRNSBlock listing Interim Review and Cancellation
27th Nov 20237:00 amRNSGlobiva Divestment
2nd Nov 20237:00 amRNSTotal Voting Rights
31st Oct 20237:00 amRNSBlink Parametric new client wins
25th Oct 20231:59 pmRNSBlock listing Interim Review
6th Oct 20237:00 amRNSBoard Update
2nd Oct 20237:00 amRNSResponse to press article
28th Sep 20233:03 pmRNSDirector/PDMR Shareholding
28th Sep 20237:00 amRNSAwards under Long Term Incentive Plan
19th Sep 20237:00 amRNSHalf-year Report for 6 months ended 30 June 2023
19th Sep 20237:00 amRNSStatement regarding change of website address
15th Sep 20237:00 amRNSInvestor presentation via Investor Meet Company
18th Jul 20237:00 amRNSTrading Update for six months ended 30 June 2023
26th Jun 20239:00 amRNSBlink Parametric new client wins
20th Jun 20237:00 amRNSBlock listing Interim Review
12th Jun 20237:00 amRNSHolding(s) in Company
9th Jun 20237:00 amRNSHolding(s) in Company
6th Jun 20239:34 amRNSHolding(s) in Company
31st May 20237:00 amRNSDirector/PDMR Shareholding
26th May 20233:17 pmRNSDirector/PDMR Shareholding
10th May 20237:00 amRNSResult of AGM
25th Apr 20237:00 amRNSBlock listing Interim Review
4th Apr 202312:36 pmRNSPosting of Annual Report and Notice of AGM
3rd Apr 20237:00 amRNSDirector/PDMR Shareholding
30th Mar 20237:00 amRNSHolding(s) in Company
28th Mar 20232:40 pmRNSDirector/PDMR Shareholding
28th Mar 20237:00 amRNSFULL YEAR RESULTS FOR YEAR ENDED 31 DECEMBER 2022
16th Feb 20237:00 amRNSBlink Parametric wins new partnerships
10th Feb 20237:00 amRNSHolding(s) in Company
24th Jan 20233:56 pmRNSStatement regarding share price movement
19th Jan 20237:00 amRNSTrading Update for Financial Year 2022
20th Dec 20227:00 amRNSBlock listing Interim Review
28th Nov 20223:52 pmRNSDirector/PDMR Shareholding
16th Nov 202211:46 amRNSDirector/PDMR Shareholding
10th Nov 202211:00 amRNSBlink Parametric wins global travel sector awards
3rd Nov 20227:00 amRNSTotal Voting Rights
25th Oct 20227:00 amRNSBlock listing Interim Review
21st Oct 20227:00 amRNSDisposal of Mexican legacy business
19th Oct 20227:00 amRNSStrategy and Change Management Programme
17th Oct 20227:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.